Nox Health logo

Nox Health Appoints Emily Buxton Taylor as Chief Financial & Operating Officer

ALPHARETTA, Ga. (November 14, 2023) – Nox Health, a global sleep health leader in sleep diagnostics and value-based sleep care management, today announced that it has named Emily Buxton Taylor as Chief Financial & Operating Officer.

In this role, Emily will assume direct responsibility for finance across Nox Health and additionally support operations that bridge Nox Health business units. With deep operational and financial expertise, Emily has more than 20 years of experience in healthcare and technology in both the public and private sectors.

“With a unique combination of financial acumen and solid operational expertise, Emily will drive performance across the company and help systematically execute and drive success of our strategies company-wide,” said Sigurjon (SK) Kristjansson, CEO of Nox Health. “Emily is a welcome addition to the Nox team as we scale and grow our company to support our range of clients, from health plan sponsors to global sleep healthcare providers.”

“I am delighted to join Nox Health and have been impressed with the team’s passion forsleep,” said Emily Buxton Taylor, Chief Financial and Operating Officer, Nox Health. “Given thestrong connection between sleep and chronic disease, I look forward to working to advanceone of Nox Health’s primary goals – to make sleep a foundational component of every benefitplan so that members and employees can improve their health.”
Arnar Thorkelsson, previous CFO of Nox Health, will now focus on supporting Nox Medical,the company’s medical technology division.

Kristjansson continued: “Arnar has been an incredible partner in developing the company to this stage, and we have grown to a point where each business unit requires a full-time executive to support our business. With Emily as our global leader, located in the US, and Arnar present in Iceland, we have a dynamic, experienced team that will help take Nox to the next level.”

Emily most recently served as Chief Operating Officer and Chief Financial Officer of Wondr Health, a company that offers complete weight and stress management programs. Previously, Emily held numerous financial positions, including Chief Financial Officer at Paradigm Tax and National HME, Chief Accounting Officer at Northstar Anesthesia, and Chief Financial Officer at Orthofix Medical, Inc. She is a certified public accountant and an active member of Financial Executives International (FEI).

Vestar Capital Partners Named to Inc.'s 2023 List of Founder-Friendly Investors

NEW YORKNov. 2, 2023 /PRNewswire/ — Vestar Capital Partners, a leading U.S. private equity firm, today announced that it has been named to Inc.'s 2023 Founder-Friendly Investors list honoring the private equity, venture capital, and debt firms with the best track records of successfully backing entrepreneurs.

The list recognizes firms with which entrepreneurs can collaborate while gaining the financial and strategic support they need to help accelerate growth. The firms on the Inc. list have successful track records of remaining actively involved with the businesses in which they invest.

Vestar has invested over $3 billion in more than 27 founder- and family-owned companies since its inception in 1988, and its current portfolio consists of 12 founder-led businesses across Consumer, Business & Technology Services and Healthcare.

"We are proud of our 35+ year track record of partnering with founders, continuing their family legacy, and sharing a commitment to their values," said Dan O'Connell, Founder and CEO of Vestar. "We appreciate Inc.'s recognition, and we are grateful for the opportunity to offer our operational expertise, long-term perspectives, and passion for building better businesses to our founder partners."

"Now more than ever, founder-led companies need financing partners that offer guidance, expertise, and understanding—not just capital. These are the private equity, venture capital, and debt firms that have founders' backs when it comes to accelerating growth," says Scott Omelianuk, editor-in-chief of Inc. Business Media.

Inc. compiled its list by surveying founders who have worked with private equity, venture capital, and debt firms about their experiences partnering with the firms and examining data on how portfolio companies have grown during these partnerships.

To see this year's complete list, go to:

About Vestar Capital Partners
Vestar Capital Partners is a leading U.S. middle-market private equity firm specializing in management buyouts and growth capital investments. Vestar invests and collaborates with incumbent management teams and private owners to build long-term enterprise value, with a focus on Consumer, Business & Technology Services and Healthcare. Since inception in 1988, Vestar funds have invested $11 billion in 92 companies – as well as more than 200 add-on acquisitions – with a total value of approximately $50 billion. For more information on Vestar, please visit

Nox Health logo

Nox Health Expands Board of Directors

ALPHARETTA, Ga., Nov. 01, 2023 (GLOBE NEWSWIRE) — Nox Health, a global sleep health leader in sleep diagnostics and value-based sleep care management, today announced the appointment of three new board members: Lloyd Dean, Chief Executive Emeritus, CommonSpirit Health; David Schlanger, Executive Chairman, Progyny; Dr. Bill Lewis, Telehealth Consultant to Fortune 500 companies.

“Sleep is the missing gap in care central to all chronic conditions,” said Sigurjon Kristjanson, CEO Nox Health. “Lloyd, David and Bill each provide the company with relevant, current and direct experience working with the plan sponsors, payers, providers and health systems who can benefit from filling that gap in care through our portfolio of value-based sleep care management solutions.”

David Schlanger is the Executive Chairman, Progyny, a leading fertility benefits management company. He previously served as the company’s CEO, where he led the company to reach key milestones, including achieving five consecutive years of industry leading clinical outcomes and becoming the first fertility and family building company to go public. Prior to Progyny, he served as the CEO of WebMD, the health information resource.

“Nox Health is differentiated in the market because it reframes sleep as a critical intervention strategy that curbs the progression of multiple chronic diseases, with a dramatic impact on plan costs and outcomes,” said David Schlanger, Executive Chairman, Progyny. “I’m delighted to be working with the Nox team to guide the commercialization strategy as we align the interests of members, plan sponsor, and providers to ensure successful outcomes.”

Lloyd Dean, Chief Executive Emeritus, CommonSpirit Health, is a nationally recognized leader within healthcare. During his time as CEO of CommonSpirit Health, he was responsible for the organization’s overall management, governance, strategy and direction. He led CommonSpirit Health and Dignity Health through significant strategic, operational, and financial transformations to its current status as a leading health care organization recognized for high quality, compassionate care, operational excellence and successful financial results.

“Given my experience in the health system space across large patient populations, I understand how sleep deprivation impacts virtually every chronic condition, like diabetes, hypertension and obesity,” said Lloyd Dean, Chief Executive Emeritus, CommonSpirit Health. “I look forward to working with the Nox Health Board of Directors as the company integrates its science-backed, behavioral interventions into traditional care models to help overcome sleep care treatment barriers, drive higher rates of adoption and reduce costs.”

Dr. Bill Lewis currently serves as Senior Consultant, through WellMedcare, on telemedicine for Fortune 500 companies and Care Delivery Organizations like Humana. He is currently engaged on Advisory Boards for several telemedicine companies such as GlobalMed, SmartMeter and Teledentist, and is on the Board of Quest Analytics. Previously, he was the Chair of the ATA/CHQI Accreditation Committee for Telemedicine currently known as the URAC Telemedicine Accreditation Program. He served as SVP for Concentra overseeing 140 clinics and 200 plus Clinic worksites and physicians for 20 years.

Dr. Bill Lewis commented: “I am proud to join the Board of Directors of Nox Health, a purpose-driven company that is focused on enabling access and improving outcomes, issues that I have dedicated my career to addressing.”

About Nox Health
Nox Health is a global leader in sleep diagnostics and value-based care on a mission to improve the health of people with chronic conditions. Our diagnostic devices are used more than two million times annually in more than 50 countries, and our value-based, outcomes-focused sleep care management program now covers more than a million employees. Headquartered in Atlanta, Georgia, and with operations in Reykjavík, Iceland and Denver, Colorado, Nox Health’s delivery of sleep care is unmatched with accurate sleep diagnostics, comprehensive, value-based sleep care management and rigorous outcomes measurement. For more information on Nox Health, please visit